IRS Issues Final Regulations Implementing the Affordable Care Act's Medical …

IRS issues final regulations implementing the Affordable Care Act's medical …
Filed under: dual diagnosis drug treatment

The IRS developed the final regulations in consultation with the Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS). The final regulations provide … Further, devices that are not used in the direct treatment …
{Source}

AxoGlia Therapeutics and the Luxembourg Centre for Systems Biomedicine …
Filed under: dual diagnosis drug treatment

Based in Luxembourg, AxoGlia is a pioneer in the development of small chemical entities having dual anti-neurodegenerative and anti-inflammatory capacities. These molecules act on two levels: the regeneration … The objective is to apply systems-level …
{Source}